相关实验视频

Updated: Jul 24, 2025

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

拓学和腺癌细胞定位数据集在迷宫中的尿路生物标志物上

Ankit Sharma¹, Michael Babich¹, Tianhong Li²

¹LabyRx Immunologic Therapeutics Limited, 2700 Stockton Blvd, Sacramento, CA, 95817, USA.

BMC research notes

|July 6, 2023

概括

迷宫素是一种新型的细胞表面标记物,在腺癌中发现. 这项研究描述了迷宫,支持其作为免疫瘤学中的泛腺癌生物标志物的潜力.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物化学生物化学

背景情况:

与瘤相关的抗原对于促进免疫瘤学的发展至关重要.
迷宫素作为一种新抗原在腺癌细胞表面上被涉及.

研究的目的:

描述迷宫的拓,氨基酸同质性和细胞表面局部.
验证迷宫作为潜在的泛腺癌标志物.

主要方法:

对蛋白质拓和同质学的生物信息学分析.
光激活细胞分类 (FACS) 用于细胞表面检测.
免疫光显微镜用于局部化和持久性.

主要成果:

迷宫蛋白被预测为具有特定功能位点的II型蛋白质.
与ASPH和结合蛋白识别的序列同质性.
在肺腺癌细胞 (A549) 上检测到迷宫素,但不是通过FACS检测到正常细胞.
免疫光检测证实了细胞表面的存在和内部化.

结论:

迷宫蛋白表现出与瘤相关的抗原的特征.
腺癌细胞表面表达支持其作为泛癌标记物的作用.
需要在免疫瘤学中进一步研究迷宫素.

关键词:

这是一种ASPH.腺癌是什么?腺癌是什么?腺癌是什么?生物标志物生物标志物迷宫中的迷宫新抗原是一种新抗原.泛瘤点是瘤的目标.瘤相关抗原与瘤相关的抗原.瘤特异性抗原是一种瘤特异性抗原.

更多相关视频

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...